Neurological manifestations in severe acute respiratory syndrome
- PMID: 16252612
Neurological manifestations in severe acute respiratory syndrome
Abstract
During the worldwide outbreak of severe acute respiratory syndrome (SARS) in 2002-2003, there were 664 probable SARS patients reported in Taiwan. SARS patients usually present with symptoms related to the respiratory system while neurological manifestations have rarely been described. There were three patients who developed axonopathic polyneuropathy 3-4 weeks after onset of SARS; their clinical condition and electrophysiological studies revealed obvious improvement at follow-up. Two SARS patients have experienced myopathy and three other patients developed rhabdomyolysis. These neuromuscular disorders in SARS patients were considered as critical illness neuropathy and myopathy, but the possibility of direct attack by SARS coronavirus on the nerve and muscle could not be excluded. Large artery ischemic stroke were described in five SARS patients with poor prognosis. Multiple factors contributed to this vascular insult included hypercoagulabe status related to both SARS coronavirous and the usage of intravenous immunoglobulin, septic and cardiogenic shock, and possible vasculitis. The relationship between SARS and above neurological problems still needs further clarification. Pathological and microbiological studies are mandatory to delineate this issue.
Similar articles
-
Neuromuscular disorders in severe acute respiratory syndrome.Arch Neurol. 2004 Nov;61(11):1669-73. doi: 10.1001/archneur.61.11.1669. Arch Neurol. 2004. PMID: 15534177
-
Clinical and laboratory features in the early stage of severe acute respiratory syndrome.J Microbiol Immunol Infect. 2006 Feb;39(1):45-53. J Microbiol Immunol Infect. 2006. PMID: 16440123
-
Olfactory neuropathy in severe acute respiratory syndrome: report of A case.Acta Neurol Taiwan. 2006 Mar;15(1):26-8. Acta Neurol Taiwan. 2006. PMID: 16599281
-
Clinical approach to the weak patient in the intensive care unit.Respir Care. 2006 Sep;51(9):1024-40; discussion 1040-1. Respir Care. 2006. PMID: 16934166 Review.
-
Severe acute respiratory syndrome in children.Pediatr Infect Dis J. 2007 Jan;26(1):68-74. doi: 10.1097/01.inf.0000247136.28950.41. Pediatr Infect Dis J. 2007. PMID: 17195709 Review.
Cited by 101 articles
-
Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.J Microbiol Immunol Infect. 2021 Mar 26:S1684-1182(21)00058-X. doi: 10.1016/j.jmii.2021.03.007. Online ahead of print. J Microbiol Immunol Infect. 2021. PMID: 34176764 Free PMC article.
-
A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?Virol J. 2021 Jun 7;18(1):120. doi: 10.1186/s12985-021-01578-0. Virol J. 2021. PMID: 34098986 Free PMC article. Review.
-
Neurologic Compromise in COVID-19: A Literature Review.J Neurol Res. 2020 Oct;10(5):164-172. doi: 10.14740/jnr619. Epub 2020 Sep 4. J Neurol Res. 2020. PMID: 33984100 Free PMC article. Review.
-
A COVID-19 Rehabilitation Prospective Surveillance Model for Use by Physiotherapists.J Clin Med. 2021 Apr 14;10(8):1691. doi: 10.3390/jcm10081691. J Clin Med. 2021. PMID: 33920035 Free PMC article.
-
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review.J Neuroimmunol. 2021 Jun 15;355:577577. doi: 10.1016/j.jneuroim.2021.577577. Epub 2021 Apr 18. J Neuroimmunol. 2021. PMID: 33895700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous